Caspases are key regulators of inflammatory and innate immune responses mediated by TLR3 in vivo

Area of Science:

• Immunology
• Cell Biology
• Molecular Medicine

Background:

• The innate immune response is crucial for tissue injury and inflammation.
• Toll-like receptors (TLRs) initiate immune signaling pathways, leading to inflammatory mediator production.
• Caspases, known for regulating apoptosis, may also play a role in cytokine production and host defense.

Purpose of the Study:

• To investigate the role of caspases in regulating innate immunity in vivo.
• To determine if the pan-caspase inhibitor z-VAD-fmk can control inflammation and cytokine production.
• To explore the impact on exocrine secretory tissues following innate immunity challenge.

Main Methods:

• Submandibular glands (SMGs) from C57BL/6 mice were used.
• Innate immunity was challenged using the TLR3 stimulant polyinosinic-polycytidylic acid (poly(I:C)).
• The effect of the pan-caspase inhibitor z-VAD-fmk was assessed.

Main Results:

• Caspases were found to control immune responses downstream of TLR3 ligation.
• z-VAD-fmk treatment demonstrated control over inflammation and cytokine production.
• Evidence suggests caspases play a regulatory role in the innate immune response.

Conclusions:

• Caspases are key regulators of innate immune responses in exocrine secretory tissues.
• Inhibiting caspases offers a potential therapeutic strategy to attenuate inflammation and organ damage.
• This study proposes a novel mechanism to prevent overactivation of the innate immune system.